Published in Clin Exp Immunol on January 01, 1991
Genetics of human X-linked immunodeficiency diseases. Clin Exp Immunol (1991) 0.79
FK506: therapeutic effects on lupus dermatoses in autoimmune-prone MRL/Mp-lpr/lpr mice. Arch Dermatol Res (1995) 0.76
The changing face of liver transplantation. Gut (1993) 0.75
FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70
Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotransplantation in the rat. Transplant Proc (1987) 12.04
FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot (Tokyo) (1987) 7.07
Prolonged survival of human-kidney homografts by immunosuppressive drug therapy. N Engl J Med (1963) 5.14
Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03
The operation. A human cardiac transplant: an interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. S Afr Med J (1967) 4.78
FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot (Tokyo) (1987) 4.54
The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J Immunol (1989) 4.30
Human renal transplantation. I. Clinical experiences with six cases of renal homotransplantation. J Urol (1963) 3.35
Inhibition of the rejection of renal homografts in dogs by Burroughs Wellcome 57-322. Surg Forum (1961) 2.54
The rejection of renal homografts. Inhibition in dogs by 6-mercaptopurine. Lancet (1960) 2.49
Toxicology of FK-506 in the Lewis rat. Transplant Proc (1987) 2.37
The side effects of FK 506 in humans. Transplant Proc (1990) 2.08
Studies of the effects of FK506 on renal allografting in the beagle dog. Transplantation (1987) 1.65
Effect of FK506 in experimental organ transplantation. Transplant Proc (1988) 1.32
Heterotopic heart transplantation in the rat receiving FK-506. Transplant Proc (1987) 1.10
Inhibition by FK506 of established lesions of collagen-induced arthritis in rats. Clin Exp Immunol (1990) 0.89
Influence of FK506 and cyclosporin A on alloantibody production and lymphocyte activation following blood transfusion. Clin Exp Immunol (1990) 0.81
Effects of FK506 on rat thymus: time-course analysis by immunoperoxidase technique and flow cytofluorometry. Clin Exp Immunol (1990) 0.78
Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet (1979) 12.29
Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet (1979) 6.10
West Nile virus infection in birds and mosquitoes, New York State, 2000. Emerg Infect Dis (2001) 4.27
Improved survival after orthotopic liver grafting. Br Med J (Clin Res Ed) (1981) 3.09
Cyclosporin A in cadaveric organ transplantation. Br Med J (Clin Res Ed) (1981) 2.67
Prolonged survival of pig orthotopic heart grafts treated with cyclosporin A. Lancet (1978) 2.57
Rapamycin for immunosuppression in organ allografting. Lancet (1989) 2.51
West Nile virus in overwintering Culex mosquitoes, New York City, 2000. Emerg Infect Dis (2001) 2.48
Cyclosporine: five years' experience in cadaveric renal transplantation. N Engl J Med (1984) 2.10
West Nile virus isolates from mosquitoes in New York and New Jersey, 1999. Emerg Infect Dis (2001) 2.05
Cyclosporin A: preliminary observations in dogs with pancreatic duodenal allografts and patients with cadaveric renal transplants. Transplant Proc (1979) 1.94
The generation of transgenic pigs as potential organ donors for humans. Nat Med (1995) 1.86
Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: protective effects of sCR1 and heparin. Transplantation (2000) 1.83
A high-resolution NMR probe in which the coil and preamplifier are cooled with liquid helium. 1984. J Magn Reson (2011) 1.75
Cyclosporin A: an immunosuppressive agent preferentially active against proliferating T cells. Transplantation (1979) 1.73
Stomach as source of bacteria colonising respiratory tract during artificial ventilation. Lancet (1978) 1.69
Human babesiosis in New York State: an epidemiological description of 136 cases. Clin Infect Dis (1992) 1.61
Umbilicoplasty: the construction of a new umbilicus and correction of umbilical stenosis without external scars. Plast Reconstr Surg (1996) 1.51
Implementation of a proficiency testing program for Lyme disease in New York State. Arch Pathol Lab Med (1994) 1.42
Trends in sexually transmitted infections (other than HIV) in older people: analysis of data from an enhanced surveillance system. Sex Transm Infect (2008) 1.41
Surveillance of sexually transmitted infections in the West Midlands using anonymised individual patient datasets from genitourinary medicine clinics. Commun Dis Public Health (2004) 1.40
Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multi-drug resistant human lung cancer cell line. Br J Cancer (1987) 1.40
Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism. J Exp Med (1992) 1.38
West Nile virus: a case study in how NY State Health Information infrastructure facilitates preparation and response to disease outbreaks. J Public Health Manag Pract (2001) 1.27
Mode of action of cyclosporin A: a new immunosuppressive agent. Transplant Proc (1979) 1.26
Progressive genetic aberrations detected by comparative genomic hybridization in squamous cell cervical cancer. Br J Cancer (2000) 1.23
FK-506 in experimental renal allografts. Transplant Proc (1987) 1.23
Structure of the bacteriophage lambda Ser/Thr protein phosphatase with sulfate ion bound in two coordination modes. Biochemistry (2000) 1.20
Long-term survival of nonhuman primates receiving life-supporting transgenic porcine kidney xenografts. Transplantation (2000) 1.19
Occupational risk of Lyme disease in endemic areas of New York State. Ann N Y Acad Sci (1988) 1.18
Cyclosporin-A in clinical organ grafting. Transplant Proc (1981) 1.16
Lyme disease in New York State: spatial pattern at a regional scale. Am J Trop Med Hyg (2001) 1.14
Antiretroviral drug concentrations in semen of HIV-infected men: differential penetration of indinavir, ritonavir and saquinavir. J Antimicrob Chemother (2001) 1.14
Concentrations of nevirapine, lamivudine and stavudine in semen of HIV-1-infected men. AIDS (2000) 1.14
Clinical pharmacology and safety evaluation of Timentin. Am J Med (1985) 1.12
Heterotopic heart transplantation in the rat receiving FK-506. Transplant Proc (1987) 1.10
Serosurvey for human babesiosis in New York. J Infect Dis (1980) 1.10
Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days. Transplantation (2000) 1.07
Three-month survival of HDAFF transgenic pig hearts transplanted into primates. Transplant Proc (1999) 1.06
Poor penetration of the male genital tract by HIV-1 protease inhibitors. AIDS (1999) 1.05
Seroprevalence and seroconversion for tick-borne diseases in a high-risk population in the northeast United States. Am J Med (1999) 1.04
Physiological aspects of pig-to-primate renal xenotransplantation. Kidney Int (2001) 1.03
Reactivity of fluoride dentifrices with artificial caries. I. Effects on early lesions: F uptake, surface hardening and remineralization. Caries Res (1987) 1.02
The use of Cyclosporin A immunosuppression in organ grafting. Immunol Rev (1982) 1.02
Overexpression of cardiac I-kappaBalpha prevents endotoxin-induced myocardial dysfunction. Am J Physiol Heart Circ Physiol (2001) 1.01
Characterization of pigs transgenic for human decay-accelerating factor. Transplantation (1997) 1.01
Prolonged survival of hamster to rat heart xenografts with cyclophosphamide therapy. Transplant Proc (1992) 1.01
Orthotopic heart transplantation in a transgenic pig-to-primate model. Transplantation (1998) 0.99
A method to study sustained antimicrobial activity of rinse and dentifrice components on biofilm viability in vivo. J Clin Periodontol (2006) 0.98
Evidence that long-term survival of concordant xenografts is achieved by inhibition of antispecies antibody production. Transplantation (1992) 0.98
A longitudinal microhardness analysis of fluoride dentifrice effects on lesion progression in vitro. Caries Res (1987) 0.97
Penetration of efavirenz into the male genital tract: drug concentrations and antiviral activity in semen and blood of HIV-1-infected men. AIDS (2001) 0.96
Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy. Transplantation (1997) 0.96
Early renal allograft rejection episodes are less aggressive with cyclosporin-A immunosuppression. Transplant Proc (1983) 0.96
Effect of oral vitamin E (alpha-tocopherol) supplementation on vascular endothelial function in Type 2 diabetes mellitus. Diabet Med (1999) 0.95
Cyclosporin A. Clinical pharmacology and therapeutic potential. Drugs (1982) 0.94
An analysis of concordant xenograft rejection in the nude rat model. Transplant Proc (1990) 0.94
The immune status of transplant recipients immunosuppressed with cyclosporin-A. Transplant Proc (1981) 0.94
Both concordant and discordant heart xenografts are rejected by athymic (nude) rats with the same tempo as in T cell competent animals. Transplant Proc (1991) 0.94
Consistent prolonged "concordant" survival of hamster-to-rat cardiac xenografts by inhibition of anti-species antibodies with methotrexate. Transplant Proc (1993) 0.93
Regulation of the complement cascade by soluble complement receptor type 1. Protective effect in experimental liver ischemia and reperfusion. Transplantation (1995) 0.93
The use of cyclosporin A in clinical organ grafting. Ann Surg (1982) 0.93
Evidence for multiple foci of eastern equine encephalitis virus (Togaviridae:Alphavirus) in central New York State. J Med Entomol (1996) 0.92
Babesiosis in Long Island. Host-parasite relationships of rodent- and human-derived Babesia microti isolates in hamsters. Am J Trop Med Hyg (1978) 0.92
The effect of long-term cyclosporin A on renal function. Lancet (1981) 0.91
Progress in xenotransplantation. Clin Nephrol (2000) 0.91
Role of p38 mitogen-activated protein kinase in cardiac myocyte secretion of the inflammatory cytokine TNF-alpha. Am J Physiol Heart Circ Physiol (2001) 0.91
New distribution records of Amblyomma americanum (L.) (Acari: Ixodidae) in New York State. J Vector Ecol (1997) 0.91
Antioxidant vitamin therapy alters burn trauma-mediated cardiac NF-kappaB activation and cardiomyocyte cytokine secretion. J Trauma (2001) 0.91
Cyclosporin G: immunosuppressive effect in dogs with renal allografts. Lancet (1985) 0.90
Inhibition of tumor necrosis factor prevents myocardial dysfunction during burn shock. Am J Physiol (1994) 0.90
Changing patterns in the incidence of Rocky Mountain Spotted Fever on Long Island (1971-1976). Am J Epidemiol (1977) 0.90
Effect of an anticalculus dentifrice on lesion progression under pH cycling conditions in vitro. Caries Res (1988) 0.90
The effects of multivitamin supplementation on mood and general well-being in healthy young adults. A laboratory and at-home mobile phone assessment. Appetite (2013) 0.90
Nanoimprinted optical fibres: Biotemplated nanostructures for SERS sensing. Biosens Bioelectron (2008) 0.90
A regional technique for the study of sensitivity to curare in human muscle. J Neurol Neurosurg Psychiatry (1975) 0.89
Renal and segmental pancreatic grafting with draining of exocrine secretion and initial continuous intravenous cyclosporin A in a patient with insulin-dependent diabetes and renal failure. Br Med J (Clin Res Ed) (1982) 0.89
Two crystal structures of the cytoplasmic molybdate-binding protein ModG suggest a novel cooperative binding mechanism and provide insights into ligand-binding specificity. J Mol Biol (2001) 0.89
Life supporting function for over one month of a transgenic porcine heart in a baboon. J Heart Lung Transplant (2000) 0.89
Kinetics of unresponsiveness induced by a short course of cyclosporin A. Transplantation (1982) 0.89
Naturally-ccurring Tyzzer's disease in the gerbil. Vet Rec (1969) 0.89
The relationship of the histocompatibility locus in the pig to allograft survival. Transplant Proc (1973) 0.89
Cyclosporine and ketoconazole. Transplantation (1984) 0.88
Recurrent vulvovaginal candidosis. Int J STD AIDS (1991) 0.88
Prolongation of kidney survival during and after cyclosporin A therapy. Transplantation (1979) 0.88
Serious interaction between cyclosporin A and sulphadimidine. Br Med J (Clin Res Ed) (1986) 0.87
Production of pigs transgenic for human decay accelerating factor. Transplant Proc (1994) 0.87
Major burn trauma in rats promotes cardiac and gastrointestinal apoptosis. Shock (1999) 0.87
Antibiotic prophylaxis for cold coagulation of the cervix? Genitourin Med (1992) 0.87
Expression of complement regulatory proteins on islets of Langerhans: a comparison between human islets and islets isolated from normal and hDAF transgenic pigs. Transplantation (2001) 0.87
Endothelial adenine uptake as an assay for cell- or complement-mediated cytotoxicity. Immunology (1977) 0.87
Antigen dependence of cyclosporin A-induced allograft acceptance. Transplantation (1982) 0.87
Increased cardiomyocyte intracellular calcium during endotoxin-induced cardiac dysfunction in guinea pigs. Pediatr Res (2000) 0.87
Cytochemical demonstration of sites of hydrogen peroxide generation and increased vascular permeability in isolated pig hearts after ischaemia and reperfusion. Microsc Res Tech (1998) 0.86
Monoclonal antibody to intercellular adhesion molecule-1 reduces cardiac contractile dysfunction after burn injury in rabbits. J Surg Res (1996) 0.86
Major transplantation antigens of pig kidney and liver. Comparisons between the whole organs and their parenchymal constituents. Transplantation (1978) 0.86
Use of synthetic polymer gels for artificial carious lesion preparation. Caries Res (1987) 0.86
Optical fibre SERS sensors. Anal Bioanal Chem (2009) 0.86
Apolipoprotein E-epsilon 4 and recurrent genital herpes in individuals co-infected with herpes simplex virus type 2 and HIV. Sex Transm Infect (2008) 0.85
Extended X-ray absorption fine structure studies on periplasmic and intracellular molybdenum-binding proteins. J Biol Inorg Chem (1999) 0.85